Health Catalyst Inc. (HCAT) - Company Sales Revenue

Health Catalyst, Inc. (HCAT) is scaling its cloud B2B platform, migrating clinics to SaaS subscriptions with AI modules to achieve profitability. The company's aggregate sales level reflects revenue dynamics where the current status is 0.27. The business relies on the DOS system for Big Data analysis in hospitals, while the implementation of AI technologies helps optimize institutional resources and support ESG goals.

Health Catalyst, Inc. (HCAT) - Revenue and Sales Volume from 07/04/2022 to 11/13/2026

Analytical breakdowns for Health Catalyst (HCAT)

- share price and consensus valuation forecast:

Price Health Catalyst Inc|HCAT - Analyst Consensus Forecast

- market capitalization indicators:

Market Value Health Catalyst, Inc.|HCAT - Real Price to Acquire Entire Company

- balance sheet net asset value indicators:

Accounting Value of a Share Health Catalyst|HCAT - Book Capitalization|Market Cap to Net Assets Ratio healthcatalyst.com|HCAT - Company Total Assets

- debt obligations and liquidity statistics:

- earnings and valuation multiples indicators:

HCAT - Company Net Income|Company Profit Forecast Health Catalyst, Inc.|HCAT - Price to Earnings Ratio|Market Cap to Future Earnings Ratio healthcatalyst.com|HCAT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Health Catalyst, Inc.|HCAT - Operating profit EBITDA|Net earnings per share for the last four quarters Health Catalyst|HCAT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months healthcatalyst.com|HCAT - Earnings growth in current year|Expected earnings per share growth for next year Health Catalyst, Inc.

- company sales and revenue statistics:

HCAT - Company Sales|Company Future Sales Health Catalyst Inc|HCAT - P/S Multiple|Forward Price to Sales Health Catalyst, Inc.

Summary company analysis:HCAT, Health Catalyst Inc

Health Catalyst, Inc. (HCAT) demonstrates resilience through the deep integration of its software into hospital infrastructure. The company's current sales volume reflects the daily cash flow from commercial operations and overall business liquidity. This metric measures the actual scale of trading activity, revealing hidden risks associated with stagnant quotes. High customer data migration costs ensure the stability of annuity income. Such B2B subscription inertia confirms the high reliability of the asset.

Analysis of competing companies